Amphastar Pharmaceuticals’ $345 Million Convertible Senior Notes Offering

Sonia Carcano
Tagged:

Goodwin advised the initial purchasers on Amphastar Pharmaceuticals, Inc.’s offering.Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the Rule 144A offering of 2.00% Convertible Senior Notes due 2029. …

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

…

This content is for Standard 1 Year members only.
Login Join Now